Information Resources

Keep up to date on the latest Cord Blood Transplation News & Updates on this Symposium! Subscribe to the Cord Blood Forum Newsletter! Send an email to: subscribe
@cordbloodforum.org or use the online subscription form on the Cord Blood Forum website. Learn More...

 

Scientific Program

printer-friendly version

Thursday, June 4, 2009
Noon- 7:00 PM Registration
6:00 - 8:00 PM Welcome Wine and Cheese Reception for all Attendees and Exhibitors- Poolside
       

Friday, June 5, 2009

Plenary Session
7:00-8:00 AM BREAKFAST in the Exhibits (On site registration available)
8:00-10:00 AM SESSION I: Clinical Results in Cord Blood Transplantation
    Chair: John Wagner, M.D.
  8:00 - 8:30 AM REVIEW: Progress in cord blood transplantation
John Wagner, MD, University of Minnesota, Minneapolis, MN
  8:30 - 8:50 AM Update of Eurocord data.
Vanderson Rocha, M.D.,PhD, Hôpital Saint-Louis, Paris, France
  8:50 - 9:10 AM Effect of stem cell sources on leukemia-free survival after allogeneic transplantation for acute lymphoblastic and myeloid leukemia.
Mary Eapen, M.D., M.S., The Medical College of Wisconsin, Milwaukee, WI
  9:10 - 9:30 AM Double unit cord blood transplantation and relapse.
Michael Veneris, M.D., University of Minnesota, Minneapolis, MN
  9:30 - 10:05 AM Discussion
Leader: Dr. Wagner
10:05 - 10:30 AM COFFEE BREAK in the Exhibits
10:30 - NOON SESSION II: Conditioning Regimens in Cord Blood Transplantation
  Chair: Juliet Barker, M.B.B.S.
  10:30 - 11:00 AM REVIEW: Conditioning regimens in cord blood transplantation.
Juliet Barker, M.B.B.S., Memorial Sloan-Kettering Cancer Center, New York, NY
  11:00 - 11:20 AM Update of the University of Minnesota experience: ablative and non-ablative conditioning regimens.
Claudio Brunstein, M.D., Ph.D., University of Minnesota, Minneapolis, MN
  11:20 - 11:40 AM Conditioning regimens: the MD Anderson approach.
Stefan Ciurea, M.D., MD Anderson Cancer Center, Houston, TX
  11:40 - NOON Discussion
Leader: Dr. Barker
NOON - 1:00 PM LUNCH in the Exhibits
1:00 - 2:30 PM SESSION III: Graft Versus Host Disease (GVHD), Infection and Relapse After Cord Blood Transplantation
    Chair: Margaret MacMillan, M.D.
  1:00 - 1:30 PM REVIEW: GVHD after cord blood transplantation.
Margaret MacMillan, M.D., University of Minnesota, Minneapolis, MN
  1:30 - 1:50 PM Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study.
Mary Eapen, M.D., M.S., The Medical College of Wisconsin, Milwaukee, WI
  1:50 - 2:10 PM Immune reconstitution after cord blood transplantation.
Paul Szabolcs, M.D., Duke University, Durham, NC
  2:10 - 2:30 PM Discussion
Leader: Dr. Macmillan
2:30 - 2:50 PM COFFEE BREAK in the Exhibits
2:50 - 5:00 PM SESSION IV: Non-Hematopoietic Uses of Cord Blood/ Regenerative Medicine
  Chair: Jan Nolta, Ph.D.
  2:50 - 3:20 PM REVIEW: Non-hematopoietic uses of cord blood.
Jan Nolta, Ph.D., University of California, Davis, Sacramento, CA
  3:20 - 3:50 PM Progress in development of treatment of spinal cord injuries with cord blood stem cells .
Wise Young, M.D., Ph.D., Rutgers University, Piscataway, NJ
  3:50 - 4:20 PM Treatment of neurologic disorders with cord blood stem cells
Joanne Kurtzberg, M.D., Duke University, Durham, NC
  4:20 - 4:40 PM Making platelets from cord blood.
Larry Lasky, M.D,. Ohio State University, Columbus, OH
  4:40 - 5:00 PM Discussion
Leader: Dr. Nolta
5:00 PM ADJOURN  
     

Saturday, June 6, 2009

Plenary Session
7:00-8:00 AM BREAKFAST in the Exhibits (Registration desk will be open for single-day registrations)
8:00 AM - 9:40 AM SESSION V: New Considerations in Cord Blood Unit Selection
  Chair: Jeffrey Miller, M.D.
  8:00 - 8:20 AM The significance of a 6/6 match in cord blood transplantation.
Juliet Barker, M.B.B.S., Memorial Sloan-Kettering Cancer Center, New York, NY
  8:20 - 8:40 AM The effect of KIR alloreactivity in cord blood transplantation.
Jeffrey Miller, M.D., University of MN, Minneapolis, MN
  8:40 - 9:00 AM The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure.
Stephen Spellman, M.S., National Marrow Donor Program, Minneapolis, MN
  9:00 - 9:20 AM Cord blood unit mononuclear cell (MNC) dose: effect on transplantation outcome and relevance to processing method and cord blood unit selection
Andromachi Scaradavou, M.D., Memorial Sloan-Kettering Cancer Center- NY Blood Center, New York, NY
  9:20 - 9:40 AM Discussion:
Leader: Dr. Miller
9:40 - 10:00 AM COFFEE BREAK in the Exhibits
10:00 AM - NOON SESSION VI Selecting the Optimal Cord Blood Unit
    Chair: John Wagner, MD
  10:00 - 10:20 AM How to perform a cord blood search.
Courtney Byam, Memorial Sloan-Kettering Cancer Center, NewYork, NY
  10:20 - 10:50 AM Optimal HLA matching in cord blood transplantation.
Effie Petersdorf, M.D., Fred Hutchinson Cancer Research Center, Seattle, WA
  10:50 - 11:15 AM HLA and cell dose considerations in selection of cord blood units for transplantation.
Eliane Gluckman, M.D., Hôpital Saint-Louis, Paris, France
  11:15 - NOON Panel Discussion: Decision making in selecting a cord blood unit
Leader: Dr. Wagner
Panelists: Barker, Gluckman, Kurtzberg,Petersdorf, Rocha
NOON - 1:00 PM LUNCH in the Exhibits

Simultaneous Sessions 1:00-5:00 PM


 

  1:00 - 2:30 PM SESSION IA: Cord Blood Processing and Evaluation of Potency
    Chair: Joanne Kurtzberg, M.D.
  1:00 -1:30 PM REVIEW: Cord blood processing methods and quality assessment.
John McMannis, Ph.D., MD Anderson Cancer Center, Houston, TX
  1:30 - 1:50 PM Cord blood unit selection: Engraftment, GVHD and overall survival using cord blood units processed using plasma depletion.
Robert Chow, M.D., A.M., StemCyte International Cord Blood Center, Covina, CA
  1:50 - 2:10 PM Cord blood unit: CFUs, ALDHbright cells and engraftment.
Joanne Kurtzberg, M.D., Duke University, Durham, NC
  2:10 - 2:30 PM Panel Discussion: CBU processing, potency and release criteria
Leader: Dr. Kurtzberg
Panelists: Chow, McMannis, Dr. Elizabeth Shpall
2:30 - 2:50 PM COFFEE BREAK in the Exhibits
  2:50 - 5:00 PM SESSION IB: Cord Blood Banking Issues and Federal Support
    Chair: Dennis Confer, M.D.
  2:50 - 3:10 PM Under-utilization of HSCT. Extent of the problem, causes, and methods of improvement.
Lawrence Petz, M.D., StemCyte International Cord Blood Center, Covina, CA
  3:10 - 3:30 PM The NMDP goal of facilitating 10,000 HSCTs in the US annually by 2015.
Dennis Confer, M.D., National Marrow Donor Program, Minneapolis, MN
  3:30 - 3:50 PM The effectiveness of cord blood transplantation to provide stem cells for minority populations.
Juliet Barker, M.B.B.S., Memorial Sloan-Kettering Cancer Center, New York, NY
  3:50 - 4:10 PM Federal government support for cord blood banking.
Robert L. Baitty M.P.P., Health Resources and Services Administration (HRSA), Rockville, MD
  4:10 - 4:30 PM Optimizing CIBMTR data reporting.
J. Douglas Rizzo, M.D., M.S., CIBMTR, The Medical College of Wisconsin, Milwaukee, WI
  4:30 - 5:00 PM Panel Discussion
Leader: Dr. Confer
Panelists: Baitty, Barker, Petz, Rizzo
5:00 PM ADJOURN

 

 

  1:00 - 2:40 PM SESSION IIA: Basic Science/ Immunobiology
    Chair: Mary Laughlin, M.D.
  1:00 -1:20 PM Strategies to improve homing and engraftment.
Sunanda Basu, Ph.D., Indiana University School of Medicine, Indianapolis, IN
  1:20 - 1:40 PM Using cord blood to identify cell cycle regulatory targets for treating leukemia.
Yan Liu, Ph.D., Memorial Sloan-Kettering Cancer Center, New York, NY
  1:40 - 2:00 PM Stromal niches distinguish reserved versus primed states of UCB hematopoietic stem cells.
Linheng Li, Ph.D., Stowers Institute for Medical Research, Kansas City, MO
  2:00 - 2:20 PM Optimization of Isolation and Further Molecular and Functional Characterization of SSEA-4+/ Oct-4+/ CD133+/ CXCR4+/ LINneg/ CD45neg Very Small Embryonic-Like (VSEL) Stem Cells Isolated from Umbilical Cord Blood.
Mariusz Ratajczak, M.D., Ph.D., D. Sci., James Graham Brown Cancer Center, University of Louisville, Louisville, KY
  2:20 - 2:40 PM Panel Discussion:
Leader: Dr. Laughlin
Panelists: Basu, Li, Liu, Ratajczak
2:40 - 3:00 PM COFFEE BREAK in the Exhibits
  3:00 - 5:00 PM SESSION IIB: Disease Specific Outcomes and New Approaches in Cord Blood Transplantation
    Chairs: Guillermo Sanz, M.D.
Franco Locatelli, M.D.
  3:00 - 3:20 PM Umbilical cord blood transplants for adults with hematologic malignancies.
Guillermo Sanz, M.D., Ph.D., Hospital Universitario La Fe, Valencia, Spain
  3:20 - 3:40 PM Cord blood transplantation for childhood AML and ALL.
Franco Locatelli, M.D., Università di Pavia, Pavia, Italy
  3:40 - 4:00 PM Cord blood transplantation for metabolic disorders.
Joanne Kurtzberg, M.D., Duke University, Durham, NC
  4:00 - 4:20 PM Ex-vivo expansion and Th1/Tc1 maturation of umbilical cord blood T cells by CD3/CD28 costimulation.
Paul Szabolcs, M.D., Duke University, Durham, NC
  4:20 - 4:40 PM Addition of cord blood to reduced intensity conditioning to augment graft-versus-tumor effect.
Partow Kebriaei, M.D., MD Anderson Cancer Center, Houston, TX
  4:30 - 5:00 PM Panel Discussion
Leaders: Dr. Locatelli, Dr. Sanz
Panelists: Kebriaei, Kurtzberg, Szabolcs
5:00 PM ADJOURN